Phase 2 Study of VX-950, Pegasys® With and Without Copegus® in Hepatitis C

Clinical trial NCT00372385 · COMPLETED

Trial details

NCT number: NCT00372385
Sponsor: Vertex Pharmaceuticals Incorporated
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis C

Start date: 2006-08-01
Primary completion: 2008-05-01
Enrollment: 334

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.